Moderna, Inc. (MRNA)
Moderna, Inc. Revenue
| Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $101.5M | $177.0M | $122.5M | $48.0M | $274.5M | $17.7B | $19.3B | $6,848.0M |
Moderna, Inc. (MRNA) Revenue comparison analysis
MRNA key stats
Discover more Stock Ideas
Undervalued stocks right now
Discover the top 20 best undervalued stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued growth stocks
Discover the top 20 best undervalued large-cap growth stocks to buy for Jan 2025, listed on the Nasdaq or NYSE.
Undervalued dividend stocks
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Jan 2025.
investors
worldwide
FAQ
1) What is Moderna, Inc.'s Revenue?
As of today, Moderna, Inc.'s last 12-month Revenue is $5,076.0M, based on the financial report for Sep 30, 2024 (Q3 2024).
2) What is Moderna, Inc.'s Revenue growth rate?
Over the last year, Moderna, Inc.'s Revenue growth was (44.3%). The average annual Revenue growth rates for Moderna, Inc. have been 36.1% over the past three years, 135.4% over the past five years.
3) Is Moderna, Inc.'s Revenue growth rate Good?
Over the last year, Moderna, Inc.'s Revenue growth was (44.3%), which is lower than industry growth of 3.1%. It indicates that Moderna, Inc.'s Revenue growth is Bad.